Canagliflozin approved for type 2 diabetes

被引：2

|

作者：

Traynor, Kate

机构：

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2013年 / 70卷 / 10期

关键词：

D O I：

10.2146/news130035

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：834 / 834

页数：1

相关论文

共 50 条

[21] Semaglutide Approved indication: type 2 diabetes
不详
AUSTRALIAN PRESCRIBER, 2020, 43 (04) : 137 - 139
[22] New medications approved for type 2 diabetes
不详
NURSE PRACTITIONER, 2018, 43 (04): : 56 - 56
[23] Rosiglitazone approved for treatment of type 2 diabetes
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (13) : 1292 - +
[24] Type-2-Diabetes: Canagliflozin reduces cardiovascular Risk
Lichert, Frank
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (22) : 1647 - 1647
[25] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes Reply
Neal, Bruce
Perkovic, Vlado
Matthews, David R.
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (21): : 2099 - 2099
[26] Effects of canagliflozin on serum magnesium in patients with type 2 diabetes
Gilbert, R.
Mende, C.
Vijapurkar, U.
Sha, S.
Davies, M. J.
Desai, M.
DIABETOLOGIA, 2016, 59 : S350 - S351
[27] Canagliflozin: An emerging treatment option for type 2 diabetes mellitus
Kaubisch, Sonja
Doan, Tam
Tan, Cynthia
Song, Jessica C.
FORMULARY, 2013, 48 (02) : 68 - 76
[28] Canagliflozin in type 2 diabetes: Differences in effects between subgroups?
Simon, Annika
DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 (06) : 431 - +
[29] Canagliflozin - something new for type 2 diabetes, but is it safe and efficacious?
Doggrell, Sheila A.
McIntyre, Kerry
EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (03) : 437 - 441
[30] A Clinical Perspective of Canagliflozin in the Management of Type 2 Diabetes Mellitus
Nardolillo, Annemarie
Kane, Michael P.
Busch, Robert S.
Watskyand, Jay
Hamilton, Robert A.
CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2014, 7 : 25 - 30

← 1 2 3 4 5 →